msullivan's picture
Push model using huggingface_hub.
81dad17 verified
metadata
tags:
  - setfit
  - sentence-transformers
  - text-classification
  - generated_from_setfit_trainer
widget:
  - text: >-
      "But PBMs operate with little to no transparency within the drug pricing
      system, and they often take advantage of their opaque position at the
      expense of patients. Their work includes establishing formularies,
      contracting with pharmacies, and negotiating rebates and discounts with
      drug manufacturers. But instead of passing these savings on to consumers,
      PBMs retain these costs, and the patients do not benefit at the pharmacy
      counter. But it's actually worse than that. Just as a rising tide lifts
      all boats, PBMs' rebate manipulation inflates health care prices generally
      and that ultimately increases the cost of patients' medications."
  - text: >-
      "That's why our state's local pharmacies are so essential. They provide
      people access to the care they need when they need it. But now, many
      pharmacies are under serious threatand our most vulnerable patients along
      with them. Over the past 14 years, the number of Oregon pharmacies has
      decreased more than 26%. Accessing medications or treatments should be
      simple, but unfortunately it's only becoming more difficult. Why is this
      happening? One reason involves middlemen insurers called pharmacy benefit
      managers (PBMs)."
  - text: >-
      "But more often, insurers and PBMs have implemented schemes called \"copay
      accumulator adjustment programs\" that prevent the value of the copay
      assistance from counting toward a patient's deductible. Faced with
      unexpectedly high costs at the pharmacy counter, patients impacted by
      these policies are less likely to adhere to treatment which can lead to
      worsened health outcomes, increased hospitalizations, and greater costs to
      the health care system. Copay accumulator policies disproportionately
      impact communities of color."
  - text: >-
      "PBMs also compile lists of drugs, called formularies, that providers of
      health benefits agree to cover; establish pharmacy networks that patients
      can access; and run their own mail-order pharmacies. Although PBMs are
      supposed to help lower costs, some of their practices may well do the
      opposite. PBMs often keep a portion of the rebates they negotiate, which
      can incentivize them to favor more expensive drugs on their formularies.
      (A $1 million drug, for example, would fetch a bigger fee than a $100
      one."
  - text: >-
      "This secrecy raises challenging questions. Do PBMs use their size and
      negotiating power to win lower net prices from drugmakers? Or do PBMs use
      their dominant market position and opaque business practices to enrich
      themselves at the expense of their customers and the rest of society? The
      answer to both these questions is, surprisingly, yes. If the contest for
      formulary placement works as it should, competition compels drugmakers to
      offer substantial discounts off the published list price. As a result,
      insurers and consumers benefit from a reduced net price for drugs.
      However, formulary competition can be undermined in various ways."
metrics:
  - accuracy
pipeline_tag: text-classification
library_name: setfit
inference: true
base_model: sentence-transformers/all-mpnet-base-v2

SetFit with sentence-transformers/all-mpnet-base-v2

This is a SetFit model that can be used for Text Classification. This SetFit model uses sentence-transformers/all-mpnet-base-v2 as the Sentence Transformer embedding model. A LogisticRegression instance is used for classification.

The model has been trained using an efficient few-shot learning technique that involves:

  1. Fine-tuning a Sentence Transformer with contrastive learning.
  2. Training a classification head with features from the fine-tuned Sentence Transformer.

Model Details

Model Description

Model Sources

Model Labels

Label Examples
Critical
  • '"That's why our state's local pharmacies are so essential. They provide people access to the care they need when they need it. But now, many pharmacies are under serious threatand our most vulnerable patients along with them. Over the past 14 years, the number of Oregon pharmacies has decreased more than 26%. Accessing medications or treatments should be simple, but unfortunately it's only becoming more difficult. Why is this happening? One reason involves middlemen insurers called pharmacy benefit managers (PBMs)."'
  • '"Unfortunately, anti-patient policies practiced by health insurance companies and health care middlemen known as pharmacy benefit managers (PBMs) impose unnecessary access and affordability barriers for epilepsy patients ? things like fail first or step therapy requirement, prior authorization, and pocketing billions in discounts without passing savings onto patients. Many patients benefit from copay coupons and copay assistance, which often come in the form of discounts from drug manufacturers and charitable organizations to help patients afford their medicine."'
  • '"But PBMs operate with little to no transparency within the drug pricing system, and they often take advantage of their opaque position at the expense of patients. Their work includes establishing formularies, contracting with pharmacies, and negotiating rebates and discounts with drug manufacturers. But instead of passing these savings on to consumers, PBMs retain these costs, and the patients do not benefit at the pharmacy counter. But it's actually worse than that. Just as a rising tide lifts all boats, PBMs' rebate manipulation inflates health care prices generally and that ultimately increases the cost of patients' medications."'
Supportive
  • '"Supporters of these bills claim they are about ?protecting patient choice,? but there?s not much of a choice when you can?t afford your medication to begin with. Patients don?t need laws that make it easier for Big Pharma to charge more. They need laws that encourage competition and lower prices. The average patient saves ? over $1,000 a year thanks to PBM negotiations. Take that away, and the only winner is the pharmaceutical industry. These bills don?t lower drug prices, they just shift the cost burden onto families, employers, and taxpayers. That?s not reform."'
  • '"This legislation, meant to punish a Pharmacy Benefit Manager, is driving up the cost of drugs for hard-working Tennesseans who were receiving their drugs at little to no cost. Not only is this in-house pharmacy losing business, but the school system is also having to include additional funding into its health insurance plan to cover additional pharmacy costs costs which were completely imposed by government action and not the rising cost of insurance. Remarkably, this means that the state government's actions are now being paid for by a local government."'
  • '"PBMs are third-party administrators of prescription medicine plans for insurance companies, businesses large and small, and government health plans. They administer the plan's drug formulary, process prescription claims and negotiate discounts with drug manufacturers. Basically, PBMs act as a check and balance like in our system of government on pharmaceutical companies, obtaining price discounts for the consumer in the form of rebates. Sanders' bill would gut their ability to negotiate, under the mistaken assumption that they are the \"bad guy,\" and it sailed through the Senate health committee by a terrifying 18-3 vote."'

Uses

Direct Use for Inference

First install the SetFit library:

pip install setfit

Then you can load this model and run inference.

from setfit import SetFitModel

# Download from the 🤗 Hub
model = SetFitModel.from_pretrained("setfit_model_id")
# Run inference
preds = model("\"PBMs also compile lists of drugs, called formularies, that providers of health benefits agree to cover; establish pharmacy networks that patients can access; and run their own mail-order pharmacies. Although PBMs are supposed to help lower costs, some of their practices may well do the opposite. PBMs often keep a portion of the rebates they negotiate, which can incentivize them to favor more expensive drugs on their formularies. (A $1 million drug, for example, would fetch a bigger fee than a $100 one.\"")

Training Details

Training Set Metrics

Training set Min Median Max
Word count 74 88.9474 100
Label Training Sample Count
Supportive 8
Critical 11

Training Hyperparameters

  • batch_size: (8, 8)
  • num_epochs: (2, 2)
  • max_steps: -1
  • sampling_strategy: oversampling
  • body_learning_rate: (2e-05, 1e-05)
  • head_learning_rate: 0.01
  • loss: CosineSimilarityLoss
  • distance_metric: cosine_distance
  • margin: 0.25
  • end_to_end: False
  • use_amp: False
  • warmup_proportion: 0.1
  • l2_weight: 0.01
  • seed: 42
  • eval_max_steps: -1
  • load_best_model_at_end: False

Training Results

Epoch Step Training Loss Validation Loss
0.0385 1 0.201 -
1.9231 50 0.1192 -

Framework Versions

  • Python: 3.10.6
  • SetFit: 1.1.1
  • Sentence Transformers: 3.4.1
  • Transformers: 4.50.1
  • PyTorch: 2.6.0
  • Datasets: 3.4.1
  • Tokenizers: 0.21.1

Citation

BibTeX

@article{https://doi.org/10.48550/arxiv.2209.11055,
    doi = {10.48550/ARXIV.2209.11055},
    url = {https://arxiv.org/abs/2209.11055},
    author = {Tunstall, Lewis and Reimers, Nils and Jo, Unso Eun Seo and Bates, Luke and Korat, Daniel and Wasserblat, Moshe and Pereg, Oren},
    keywords = {Computation and Language (cs.CL), FOS: Computer and information sciences, FOS: Computer and information sciences},
    title = {Efficient Few-Shot Learning Without Prompts},
    publisher = {arXiv},
    year = {2022},
    copyright = {Creative Commons Attribution 4.0 International}
}